Gamgee — Australian multicenter veterinary trial
Specialty hospital / research center
1 current cancer treatment or research opportunity
About the Gamgee Australian trial
Gamgee coordinates an Australian investigational cancer-vaccine study for dogs. It designs a personalized mRNA vaccine using a dog's tumor and blood samples and works with a referring or treating veterinarian on screening, sampling and administration; participating clinics are assigned case by case.
Gamgee trial and owner registration →
Who the current listings are forDogs
Cancer types currently listedMast Cell Tumor
Current options at Gamgee — Australian multicenter veterinary trial
Open an option to see who may qualify, locations, costs or coverage, contact details and the official source.
Personalized mRNA therapeutic cancer vaccine for canine mast cell tumor
Gamgee — Australian multicenter veterinary trial · Australia
Currently enrolling — Australian clinical trial
What is being offered: Patient-specific therapeutic mRNA neoantigen vaccine after tumor and blood sampling; administered by the treating veterinarian
Who may qualify: Confirmed cancer diagnosis required
Costs / coverage: 💬 Study pricing and coverage are not publicly stated. Gamgee says its coordinator explains potential costs and what may be covered after registration; confirm biopsy, sequencing, vaccine, veterinary care and travel costs before agreeing.
Contact: Owner application at gamgee.io/apply/; veterinary referrals via gamgee.io/vet/ or partners@gamgee.io; questions: hello@gamgee.io
Official study / enrollment information →
Before you contact the center
A listing here does not mean every pet will qualify. Enrollment can change, and the study team makes the final decision after reviewing your pet’s diagnosis, records and previous treatment.
Have the pathology report, recent imaging and treatment history ready. Ask whether a referral is required, which visits must happen in person and what the study pays for before making travel plans.
Check all options for your pet →
Free to use. No registration or paid report.
